Johnson & Johnson is ramping up its capacity for producing 1 billion doses of an experimental lead vaccine candidate for SARS-CoV-2 -- known as coronavirus.
Facebook is committing $100 million in grant money and promised ad spending for helping news outlets dealing with financial struggles due to the COVID-19 outbreak.
Gilead is expanding on its access to the experimental anti-coronavirus drug remdesivir in order to accelerate the emergency use for multiple severely ill patients.